Entrada Therapeutics (TRDA) Enterprise Value (2021 - 2026)
Entrada Therapeutics' Enterprise Value was $187.29 million in Q2 2026, up 2.3% from $183.11 million a year earlier but down 54.7% from the prior quarter.
Powered by 
Analysis
Entrada Therapeutics (TRDA) Enterprise Value (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Entrada Therapeutics' Enterprise Value was -$72.83 million through Jun 30, 2026; for FY2025, it was $303.17 million, down 44.7% from FY2024.
- In earlier years, Enterprise Value was $548.45 million in FY2024 (+25.5%), $436.97 million in FY2023 (+15.2%), $379.3 million in FY2022 and -$183.76 million in FY2021.
- Quarterly Enterprise Value has moved between -$183.76 million (Q4 2021) and $548.45 million (Q4 2024) over five years.
- Compared with a year earlier, Enterprise Value was higher in four of the last eight quarters, with an average decline of 14.0%.
- The best year-over-year quarter for Enterprise Value over five years was Q1 2023 (growth of 752.0%); the worst was Q3 2025 (a decline of 75.3%).
- Per Business Quant data, TRDA's Enterprise Value in the three quarters before Q2 2026 was $413.47 million (Q1 2026), $303.17 million (Q4 2025) and $128.39 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Entrada Therapeutics | 242.19 Mn | 242.19 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 187.29 Mn |
| Mar 31, 2026 | 413.47 Mn |
| Dec 31, 2025 | 303.17 Mn |
| Sep 30, 2025 | 128.39 Mn |
| Jun 30, 2025 | 183.11 Mn |
| Mar 31, 2025 | 275.16 Mn |
| Dec 31, 2024 | 548.45 Mn |
| Sep 30, 2024 | 519.61 Mn |
| Jun 30, 2024 | 344.46 Mn |
| Mar 31, 2024 | 407.73 Mn |
| Dec 31, 2023 | 436.97 Mn |
| Sep 30, 2023 | 474.89 Mn |
| Jun 30, 2023 | 422.99 Mn |
| Mar 31, 2023 | 252.79 Mn |
| Dec 31, 2022 | 379.30 Mn |
| Sep 30, 2022 | 278.12 Mn |
| Jun 30, 2022 | 136.79 Mn |
| Mar 31, 2022 | 29.67 Mn |
| Dec 31, 2021 | -183.76 Mn |
API Access
Entrada Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=TRDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "TRDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=TRDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();